Journal of Clinical Endocrinology & Metabolism, Vol 80, 3151-3154, Copyright © 1995 by Endocrine Society

ARTICLES

The glucose clamp procedure activates the sympathetic nervous system even in the absence of hyperinsulinemia

A Moan, A Hoieggen, G Nordby, K Birkeland, I Eide and SE Kjeldsen
Department of Internal Medicine, Ullevaal Hospital, Oslo, Norway.

There is a well established connection between hyperinsulinemia and hypertension, and activation of the sympathetic nervous system (SNS) by insulin has been proposed as one mechanism. In short term infusion studies, hyperinsulinemia during the euglycemic glucose clamp examination is associated with increased norepinephrine concentration. However, many of the studies lack sufficient control groups. The euglycemic glucose clamp examination could possibly, by discomfort from iv cannulas, the use of heating cuffs, and prolonged immobilization, by itself increase SNS activity. To examine this, we included nine controls, who had saline instead of glucose and insulin infused iv, among other healthy young men (n = 50) who underwent the euglycemic hyperinsulinemic glucose clamp. During hyperinsulinemic clamp, the plasma norepinephrine concentration increased from 0.87 +/- 0.06 to 1.06 +/- 0.05 nmol/L; in the control study, it increased from 0.99 +/- 0.14 to 1.21 +/- 0.11 nmol/L, a significant treatment effect (P < 0.001, by repeated measures analysis of variance), but no group x treatment effect (P = 0.17), i.e. there was no difference between the groups. There were no significant changes in systolic or diastolic blood pressure, heart rate, or plasma epinephrine concentration during the clamps, nor any differences between the groups. We conclude that the increase in plasma norepinephrine concentration observed during an euglycemic glucose clamp examination may be attributed to the procedure itself, and that the inclusion of a control group is mandatory when assessing SNS activity.

This article has been cited by other articles:

				S. D West, D. J Nicoll, T. M Wallace, D. R Matthews, and J. R Stradling Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes Thorax, November 1, 2007; 62(11): 969 - 974. [Abstract] [Full Text] [PDF]

				N. M. Punjabi Improvement of Metabolic Function in Sleep Apnea: The Power of Positive Pressure Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 139 - 140. [Full Text] [PDF]

				D. S. Paramore, C. G. Fanelli, S. D. Shah, and P. E. Cryer Forearm norepinephrine spillover during standing, hyperinsulinemia, and hypoglycemia Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E872 - E881. [Abstract] [Full Text] [PDF]

				I. Seljeflot, A. Moan, S. Kjeldsen, E. Sandvik, and H. Arnesen Effect of Angiotensin II Receptor Blockade on Fibrinolysis During Acute Hyperinsulinemia in Patients With Essential Hypertension Hypertension, June 1, 1996; 27(6): 1299 - 1304. [Abstract] [Full Text]